** Shares of medical device maker Inspire Medical Systems
INSP.N rise ~12% to $141 premarket
** Co forecasts FY24 revenue between $788 mln and $798 mln,
above analysts' estimates of $787.92 mln - LSEG data
** INSP sees preliminary Q2 total rev of $195.9 mln, with
U.S. sales expected to contribute $187.8 mln
** Analysts expect $186.25 mln in total rev and $179.80 mln
in U.S. sales
** Co plans to report its complete Q2 results on Aug. 6
** As of last close, stock down 38.2% YTD
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))